Abstract
Ornithine transcarbamylase deficiency is an X-linked disease with a wide range of clinical severity and manifestation age both in males and females. Here, we describe a case which is caused by a novel c.78-1G>A splice site mutation, which on mRNA level leads to a 1-bp deletion and a frameshift (c.78delG (p.C27Vfs*11)) in OTC exon 2 in a young girl. The same mutation has been detected in a mosaic state in her asymptomatic father.
Similar content being viewed by others
References
Brusilow S. W. and Maestri N. E. 1996 Urea cycle disorders: diagnosis, pathophysiology, and therapy. Adv. Pediatr. 43, 127–170.
Caldovic L., Abdikarim I., Narain S., Tuchman M. and Morizono H. 2015 Genotype-phenotype correlations in ornithine transcarbamylase deficiency: a mutation update. J. Genet. Genomics 42,181–194.
Filatova A. Y., Vasilyeva T. A., Marakhonov A. V., Voskresenskaya A. A., Zinchenko R. A. and Skoblov M. Y. 2019 Functional reassessment of PAX6 single nucleotide variants by in vitro splicing assay. Eur. J. Hum. Genet. 27, 488–493.
Gyato K., Wray J., Huang Z. J., Yudkoff M. and Batshaw M. L. 2004 Metabolic and neuropsychological phenotype in women heterozygous for ornithine transcarbamylase deficiency. Ann. Neurol. 55, 80–86.
Laemmle A., Gallagher R. C., Keogh A., Stricker T., Gautschi M., Nuoffer J. M. et al. 2016 Frequency and pathophysiology of acute liver failure in ornithine transcarbamylase deficiency (OTCD). PLoS One 11, e0153358.
Lee T., Misaki M., Shimomura H., Tanaka Y., Yoshida S., Murayama K. et al. 2018 Late-onset ornithine transcarbamylase deficiency caused by a somatic mosaic mutation. Hum. Genome Var. 16, 22.
Qin L., Wang J., Tian X., Yu H., Truong C., Mitchell J. J. et al. 2016 Detection and quantification of mosaic mutations in disease genes by next-generation sequencing. J. Mol. Diagn. 18, 446–453.
Shao Y., Jiang M., Lin Y., Mei H., Zhang W., Cai Y. et al. 2017 Clinical and mutation analysis of 24 Chinese patients with ornithine transcarbamylase deficiency. Clin. Genet. 92, 318–322.
Testai F. D. and Gorelick P. B. 2010 Inherited metabolic disorders and stroke part 2: homocystinuria, organic acidurias, and urea cycle disorders. Arch. Neurol. 67, 148–153.
Thurlow V. R., Asafu-Adjaye M., Agalou S. and Rahman Y. 2010 Fatal ammonia toxicity in an adult due to an undiagnosed urea cycle defect: under-recognition of ornithine transcarbamylase deficiency. Ann. Clin. Biochem. 47, 279–281.
Yamaguchi S., Brailey L. L., Morizono H., Bale A. E. and Tuchman M. 2006 Mutations and polymorphisms in the human ornithine transcarbamylase (OTC) gene. Hum. Mutat. 27, 626–632.
Yeo G. and Burge C. B. 2004 Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J. Comput. Biol. 11, 377–394.
Acknowledgement
This research was carried out within the state assignment of Ministry of Science and Higher Education of the Russian Federation.
Author information
Authors and Affiliations
Corresponding author
Additional information
Corresponding editor: Indrajit Nanda
Rights and permissions
About this article
Cite this article
Olga, S., Natalia, S., Igor, B. et al. A novel splice site mutation in OTC gene of a female with ornithine transcarbamylase deficiency and her asymptomatic mosaic father. J Genet 99, 29 (2020). https://doi.org/10.1007/s12041-020-1189-8
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12041-020-1189-8